MedPath

Metoprolol Tartrate

These highlights do not include all the information needed to use METOPROLOL TARTRATE INJECTION safely and effectively. See full prescribing information for METOPROLOL TARTRATE INJECTION. METOPROLOL TARTRATE injection, for intravenous use Initial U.S. Approval: 1978

Approved
Approval ID

f0370951-ab26-d4d1-b857-57518f3c4175

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 27, 2023

Manufacturers
FDA

Almaject, Inc.

DUNS: 116626205

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

metoprolol tartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72611-740
Application NumberANDA204205
Product Classification
M
Marketing Category
C73584
G
Generic Name
metoprolol tartrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 15, 2020
FDA Product Classification

INGREDIENTS (3)

metoprolol tartrateActive
Quantity: 1 mg in 1 mL
Code: W5S57Y3A5L
Classification: ACTIB
sodium chlorideInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Metoprolol Tartrate - FDA Drug Approval Details